US-based biotech firm 23andMe's CEO Anne Wojcicki told Fortune, "I think we can navigate and land this plane...but it's absolutely complicated," after her firm's entire board resigned over her plans to take 23andMe private. "I've always said...since very beginning, I don't need to be in charge," Wojcicki said, adding, "There's no ego for me. I care about vision and mission."